Avadel Pharmaceuticals PLC (AVDL) — Net Asset Quality Index
Avadel Pharmaceuticals PLC (AVDL) has a Net Asset Quality Index of 49.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $199.45 Million minus total liabilities of $101.22 Million yields net assets of $98.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Avadel Pharmaceuticals PLC for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Avadel Pharmaceuticals PLC Net Asset Quality Index Over Time (1996–2024)
This chart shows how Avadel Pharmaceuticals PLC's Net Asset Quality Index has evolved across 29 annual periods from 1996 to 2024. As of September 2025, the index stands at 49.2%, representing net assets of $98.22 Million against total assets of $199.45 Million USD. For live market cap and overall valuation, see AVDL market cap overview.
Annual Net Asset Quality Index for Avadel Pharmaceuticals PLC (1996–2024)
The table below presents the year-by-year Net Asset Quality Index for Avadel Pharmaceuticals PLC from 1996 to 2024, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check AVDL PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 45.0% | $73.85 Million | $164.24 Million | $90.39 Million | ▼ -8.3 pp |
| 2023 | 53.3% | $87.74 Million | $164.70 Million | $76.96 Million | ▲ +69.2 pp |
| 2022 | -15.9% | $-21.14 Million | $132.78 Million | $153.93 Million | ▼ -47.6 pp |
| 2021 | 31.6% | $78.24 Million | $247.26 Million | $169.02 Million | ▼ -20.4 pp |
| 2020 | 52.1% | $162.27 Million | $311.64 Million | $149.37 Million | ▲ +71.4 pp |
| 2019 | -19.3% | $-29.20 Million | $151.44 Million | $180.63 Million | ▼ -20.7 pp |
| 2018 | 1.5% | $2.78 Million | $190.30 Million | $187.52 Million | ▼ -32.1 pp |
| 2017 | 33.5% | $84.56 Million | $252.11 Million | $167.54 Million | ▲ +16.4 pp |
| 2016 | 17.1% | $42.07 Million | $245.48 Million | $203.41 Million | ▼ -14.4 pp |
| 2015 | 31.6% | $67.86 Million | $214.98 Million | $147.11 Million | ▲ +17.3 pp |
| 2014 | 14.3% | $24.89 Million | $174.21 Million | $149.31 Million | ▲ +22.5 pp |
| 2013 | -8.2% | $-9.51 Million | $116.25 Million | $125.76 Million | ▼ -34.2 pp |
| 2012 | 26.0% | $30.50 Million | $117.31 Million | $86.81 Million | ▼ -16.9 pp |
| 2011 | 42.9% | $29.79 Million | $69.40 Million | $39.61 Million | ▼ -5.7 pp |
| 2010 | 48.7% | $36.30 Million | $74.61 Million | $38.31 Million | ▲ +1.1 pp |
| 2009 | 47.6% | $44.86 Million | $94.30 Million | $49.43 Million | ▼ -5.3 pp |
| 2008 | 52.8% | $48.55 Million | $91.86 Million | $43.31 Million | ▼ -1.0 pp |
| 2007 | 53.9% | $54.63 Million | $101.40 Million | $46.77 Million | ▼ -9.7 pp |
| 2006 | 63.6% | $73.03 Million | $114.89 Million | $41.87 Million | ▼ -6.1 pp |
| 2005 | 69.7% | $86.65 Million | $124.35 Million | $37.70 Million | ▼ -10.5 pp |
| 2004 | 80.2% | $116.76 Million | $145.61 Million | $28.85 Million | ▲ +7.8 pp |
| 2003 | 72.3% | $92.06 Million | $127.25 Million | $35.19 Million | ▲ +19.1 pp |
| 2002 | 53.2% | $12.29 Million | $23.08 Million | $10.79 Million | ▲ +11.9 pp |
| 2001 | 41.4% | $7.51 Million | $18.14 Million | $10.63 Million | ▼ -12.1 pp |
| 2000 | 53.4% | $10.88 Million | $20.36 Million | $9.48 Million | ▼ -7.3 pp |
| 1999 | 60.8% | $9.07 Million | $14.92 Million | $5.85 Million | ▼ -9.5 pp |
| 1998 | 70.2% | $17.79 Million | $25.32 Million | $7.53 Million | ▲ +3.7 pp |
| 1997 | 66.5% | $14.30 Million | $21.50 Million | $7.20 Million | ▼ -10.7 pp |
| 1996 | 77.3% | $23.10 Million | $29.90 Million | $6.80 Million | — |